Global Herpes Zoster Ophthalmicus Drug Market Size, Status and Forecast 2021-2027

眼部帯状ヘルペス治療薬の世界市場規模・現状・予測2021年-2027年

◆タイトル:Global Herpes Zoster Ophthalmicus Drug Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR2814
◆調査・発行会社:QYResearch
◆発行日:2021年4月
◆ページ数:92
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、主要地域
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥444,600見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥666,900見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥889,200見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査資料では、眼部帯状ヘルペス治療薬の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(経口薬、外用薬、注射薬)、用途別市場規模(病院薬局、小売薬局、オンライン薬局)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・眼部帯状ヘルペス治療薬の市場動向
・企業の競争状況、市場シェア
・眼部帯状ヘルペス治療薬の種類別市場規模(経口薬、外用薬、注射薬)
・眼部帯状ヘルペス治療薬の用途別市場規模(病院薬局、小売薬局、オンライン薬局)
・眼部帯状ヘルペス治療薬の北米市場規模2016-2027(アメリカ、カナダ)
・眼部帯状ヘルペス治療薬の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・眼部帯状ヘルペス治療薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・眼部帯状ヘルペス治療薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・眼部帯状ヘルペス治療薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Abbott、Novartis、GlaxoSmithKline、Fresenius、SteriMax、Cadila Pharmaceuticals、Shermco、TEVA、Cipla、Mylan、Foamix、Merck)
・結論

Herpes Zoster Ophthalmicus is a diseases which activates itself due to the reoccurrence of varicella zoster virus infection. The disease involves eye and damages the eye and its surrounding structures due to inflammation of nerves.

Market Analysis and Insights: Global Herpes Zoster Ophthalmicus Drug Market
The global Herpes Zoster Ophthalmicus Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Herpes Zoster Ophthalmicus Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Herpes Zoster Ophthalmicus Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Herpes Zoster Ophthalmicus Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Herpes Zoster Ophthalmicus Drug market.

Global Herpes Zoster Ophthalmicus Drug Scope and Market Size
Herpes Zoster Ophthalmicus Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Herpes Zoster Ophthalmicus Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral Drug
Topical Drug
Injectable Drug

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Novartis
GlaxoSmithKline
Fresenius
SteriMax
Cadila Pharmaceuticals
Shermco
TEVA
Cipla
Fresenius

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Herpes Zoster Ophthalmicus Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral Drug
1.2.3 Topical Drug
1.2.4 Injectable Drug
1.3 Market by Application
1.3.1 Global Herpes Zoster Ophthalmicus Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Herpes Zoster Ophthalmicus Drug Market Perspective (2016-2027)
2.2 Herpes Zoster Ophthalmicus Drug Growth Trends by Regions
2.2.1 Herpes Zoster Ophthalmicus Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Herpes Zoster Ophthalmicus Drug Historic Market Share by Regions (2016-2021)
2.2.3 Herpes Zoster Ophthalmicus Drug Forecasted Market Size by Regions (2022-2027)
2.3 Herpes Zoster Ophthalmicus Drug Industry Dynamic
2.3.1 Herpes Zoster Ophthalmicus Drug Market Trends
2.3.2 Herpes Zoster Ophthalmicus Drug Market Drivers
2.3.3 Herpes Zoster Ophthalmicus Drug Market Challenges
2.3.4 Herpes Zoster Ophthalmicus Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Herpes Zoster Ophthalmicus Drug Players by Revenue
3.1.1 Global Top Herpes Zoster Ophthalmicus Drug Players by Revenue (2016-2021)
3.1.2 Global Herpes Zoster Ophthalmicus Drug Revenue Market Share by Players (2016-2021)
3.2 Global Herpes Zoster Ophthalmicus Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Herpes Zoster Ophthalmicus Drug Revenue
3.4 Global Herpes Zoster Ophthalmicus Drug Market Concentration Ratio
3.4.1 Global Herpes Zoster Ophthalmicus Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Herpes Zoster Ophthalmicus Drug Revenue in 2020
3.5 Herpes Zoster Ophthalmicus Drug Key Players Head office and Area Served
3.6 Key Players Herpes Zoster Ophthalmicus Drug Product Solution and Service
3.7 Date of Enter into Herpes Zoster Ophthalmicus Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Herpes Zoster Ophthalmicus Drug Breakdown Data by Type
4.1 Global Herpes Zoster Ophthalmicus Drug Historic Market Size by Type (2016-2021)
4.2 Global Herpes Zoster Ophthalmicus Drug Forecasted Market Size by Type (2022-2027)

5 Herpes Zoster Ophthalmicus Drug Breakdown Data by Application
5.1 Global Herpes Zoster Ophthalmicus Drug Historic Market Size by Application (2016-2021)
5.2 Global Herpes Zoster Ophthalmicus Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Herpes Zoster Ophthalmicus Drug Market Size (2016-2027)
6.2 North America Herpes Zoster Ophthalmicus Drug Market Size by Type
6.2.1 North America Herpes Zoster Ophthalmicus Drug Market Size by Type (2016-2021)
6.2.2 North America Herpes Zoster Ophthalmicus Drug Market Size by Type (2022-2027)
6.2.3 North America Herpes Zoster Ophthalmicus Drug Market Size by Type (2016-2027)
6.3 North America Herpes Zoster Ophthalmicus Drug Market Size by Application
6.3.1 North America Herpes Zoster Ophthalmicus Drug Market Size by Application (2016-2021)
6.3.2 North America Herpes Zoster Ophthalmicus Drug Market Size by Application (2022-2027)
6.3.3 North America Herpes Zoster Ophthalmicus Drug Market Size by Application (2016-2027)
6.4 North America Herpes Zoster Ophthalmicus Drug Market Size by Country
6.4.1 North America Herpes Zoster Ophthalmicus Drug Market Size by Country (2016-2021)
6.4.2 North America Herpes Zoster Ophthalmicus Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Herpes Zoster Ophthalmicus Drug Market Size (2016-2027)
7.2 Europe Herpes Zoster Ophthalmicus Drug Market Size by Type
7.2.1 Europe Herpes Zoster Ophthalmicus Drug Market Size by Type (2016-2021)
7.2.2 Europe Herpes Zoster Ophthalmicus Drug Market Size by Type (2022-2027)
7.2.3 Europe Herpes Zoster Ophthalmicus Drug Market Size by Type (2016-2027)
7.3 Europe Herpes Zoster Ophthalmicus Drug Market Size by Application
7.3.1 Europe Herpes Zoster Ophthalmicus Drug Market Size by Application (2016-2021)
7.3.2 Europe Herpes Zoster Ophthalmicus Drug Market Size by Application (2022-2027)
7.3.3 Europe Herpes Zoster Ophthalmicus Drug Market Size by Application (2016-2027)
7.4 Europe Herpes Zoster Ophthalmicus Drug Market Size by Country
7.4.1 Europe Herpes Zoster Ophthalmicus Drug Market Size by Country (2016-2021)
7.4.2 Europe Herpes Zoster Ophthalmicus Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Herpes Zoster Ophthalmicus Drug Market Size (2016-2027)
8.2 Asia-Pacific Herpes Zoster Ophthalmicus Drug Market Size by Type
8.2.1 Asia-Pacific Herpes Zoster Ophthalmicus Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Herpes Zoster Ophthalmicus Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Herpes Zoster Ophthalmicus Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Herpes Zoster Ophthalmicus Drug Market Size by Application
8.3.1 Asia-Pacific Herpes Zoster Ophthalmicus Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Herpes Zoster Ophthalmicus Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Herpes Zoster Ophthalmicus Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Herpes Zoster Ophthalmicus Drug Market Size by Region
8.4.1 Asia-Pacific Herpes Zoster Ophthalmicus Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Herpes Zoster Ophthalmicus Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Herpes Zoster Ophthalmicus Drug Market Size (2016-2027)
9.2 Latin America Herpes Zoster Ophthalmicus Drug Market Size by Type
9.2.1 Latin America Herpes Zoster Ophthalmicus Drug Market Size by Type (2016-2021)
9.2.2 Latin America Herpes Zoster Ophthalmicus Drug Market Size by Type (2022-2027)
9.2.3 Latin America Herpes Zoster Ophthalmicus Drug Market Size by Type (2016-2027)
9.3 Latin America Herpes Zoster Ophthalmicus Drug Market Size by Application
9.3.1 Latin America Herpes Zoster Ophthalmicus Drug Market Size by Application (2016-2021)
9.3.2 Latin America Herpes Zoster Ophthalmicus Drug Market Size by Application (2022-2027)
9.3.3 Latin America Herpes Zoster Ophthalmicus Drug Market Size by Application (2016-2027)
9.4 Latin America Herpes Zoster Ophthalmicus Drug Market Size by Country
9.4.1 Latin America Herpes Zoster Ophthalmicus Drug Market Size by Country (2016-2021)
9.4.2 Latin America Herpes Zoster Ophthalmicus Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Herpes Zoster Ophthalmicus Drug Market Size (2016-2027)
10.2 Middle East & Africa Herpes Zoster Ophthalmicus Drug Market Size by Type
10.2.1 Middle East & Africa Herpes Zoster Ophthalmicus Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Herpes Zoster Ophthalmicus Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Herpes Zoster Ophthalmicus Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Herpes Zoster Ophthalmicus Drug Market Size by Application
10.3.1 Middle East & Africa Herpes Zoster Ophthalmicus Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Herpes Zoster Ophthalmicus Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Herpes Zoster Ophthalmicus Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Herpes Zoster Ophthalmicus Drug Market Size by Country
10.4.1 Middle East & Africa Herpes Zoster Ophthalmicus Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Herpes Zoster Ophthalmicus Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Herpes Zoster Ophthalmicus Drug Introduction
11.1.4 Abbott Revenue in Herpes Zoster Ophthalmicus Drug Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Herpes Zoster Ophthalmicus Drug Introduction
11.2.4 Novartis Revenue in Herpes Zoster Ophthalmicus Drug Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Herpes Zoster Ophthalmicus Drug Introduction
11.3.4 GlaxoSmithKline Revenue in Herpes Zoster Ophthalmicus Drug Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Fresenius
11.4.1 Fresenius Company Details
11.4.2 Fresenius Business Overview
11.4.3 Fresenius Herpes Zoster Ophthalmicus Drug Introduction
11.4.4 Fresenius Revenue in Herpes Zoster Ophthalmicus Drug Business (2016-2021)
11.4.5 Fresenius Recent Development
11.5 SteriMax
11.5.1 SteriMax Company Details
11.5.2 SteriMax Business Overview
11.5.3 SteriMax Herpes Zoster Ophthalmicus Drug Introduction
11.5.4 SteriMax Revenue in Herpes Zoster Ophthalmicus Drug Business (2016-2021)
11.5.5 SteriMax Recent Development
11.6 Cadila Pharmaceuticals
11.6.1 Cadila Pharmaceuticals Company Details
11.6.2 Cadila Pharmaceuticals Business Overview
11.6.3 Cadila Pharmaceuticals Herpes Zoster Ophthalmicus Drug Introduction
11.6.4 Cadila Pharmaceuticals Revenue in Herpes Zoster Ophthalmicus Drug Business (2016-2021)
11.6.5 Cadila Pharmaceuticals Recent Development
11.7 Shermco
11.7.1 Shermco Company Details
11.7.2 Shermco Business Overview
11.7.3 Shermco Herpes Zoster Ophthalmicus Drug Introduction
11.7.4 Shermco Revenue in Herpes Zoster Ophthalmicus Drug Business (2016-2021)
11.7.5 Shermco Recent Development
11.8 TEVA
11.8.1 TEVA Company Details
11.8.2 TEVA Business Overview
11.8.3 TEVA Herpes Zoster Ophthalmicus Drug Introduction
11.8.4 TEVA Revenue in Herpes Zoster Ophthalmicus Drug Business (2016-2021)
11.8.5 TEVA Recent Development
11.9 Cipla
11.9.1 Cipla Company Details
11.9.2 Cipla Business Overview
11.9.3 Cipla Herpes Zoster Ophthalmicus Drug Introduction
11.9.4 Cipla Revenue in Herpes Zoster Ophthalmicus Drug Business (2016-2021)
11.9.5 Cipla Recent Development
11.10 Mylan
11.10.1 Mylan Company Details
11.10.2 Mylan Business Overview
11.10.3 Mylan Herpes Zoster Ophthalmicus Drug Introduction
11.10.4 Mylan Revenue in Herpes Zoster Ophthalmicus Drug Business (2016-2021)
11.10.5 Mylan Recent Development
11.11 Foamix
11.11.1 Foamix Company Details
11.11.2 Foamix Business Overview
11.11.3 Foamix Herpes Zoster Ophthalmicus Drug Introduction
11.11.4 Foamix Revenue in Herpes Zoster Ophthalmicus Drug Business (2016-2021)
11.11.5 Foamix Recent Development
11.12 Merck
11.12.1 Merck Company Details
11.12.2 Merck Business Overview
11.12.3 Merck Herpes Zoster Ophthalmicus Drug Introduction
11.12.4 Merck Revenue in Herpes Zoster Ophthalmicus Drug Business (2016-2021)
11.12.5 Merck Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Herpes Zoster Ophthalmicus Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral Drug
Table 3. Key Players of Topical Drug
Table 4. Key Players of Injectable Drug
Table 5. Global Herpes Zoster Ophthalmicus Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Herpes Zoster Ophthalmicus Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Herpes Zoster Ophthalmicus Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Herpes Zoster Ophthalmicus Drug Market Share by Regions (2016-2021)
Table 9. Global Herpes Zoster Ophthalmicus Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Herpes Zoster Ophthalmicus Drug Market Share by Regions (2022-2027)
Table 11. Herpes Zoster Ophthalmicus Drug Market Trends
Table 12. Herpes Zoster Ophthalmicus Drug Market Drivers
Table 13. Herpes Zoster Ophthalmicus Drug Market Challenges
Table 14. Herpes Zoster Ophthalmicus Drug Market Restraints
Table 15. Global Herpes Zoster Ophthalmicus Drug Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Herpes Zoster Ophthalmicus Drug Market Share by Players (2016-2021)
Table 17. Global Top Herpes Zoster Ophthalmicus Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herpes Zoster Ophthalmicus Drug as of 2020)
Table 18. Ranking of Global Top Herpes Zoster Ophthalmicus Drug Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Herpes Zoster Ophthalmicus Drug Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Herpes Zoster Ophthalmicus Drug Product Solution and Service
Table 22. Date of Enter into Herpes Zoster Ophthalmicus Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Herpes Zoster Ophthalmicus Drug Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Herpes Zoster Ophthalmicus Drug Revenue Market Share by Type (2016-2021)
Table 26. Global Herpes Zoster Ophthalmicus Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Herpes Zoster Ophthalmicus Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Herpes Zoster Ophthalmicus Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Herpes Zoster Ophthalmicus Drug Revenue Market Share by Application (2016-2021)
Table 30. Global Herpes Zoster Ophthalmicus Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Herpes Zoster Ophthalmicus Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Herpes Zoster Ophthalmicus Drug Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Herpes Zoster Ophthalmicus Drug Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Herpes Zoster Ophthalmicus Drug Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Herpes Zoster Ophthalmicus Drug Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Herpes Zoster Ophthalmicus Drug Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Herpes Zoster Ophthalmicus Drug Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Herpes Zoster Ophthalmicus Drug Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Herpes Zoster Ophthalmicus Drug Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Herpes Zoster Ophthalmicus Drug Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Herpes Zoster Ophthalmicus Drug Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Herpes Zoster Ophthalmicus Drug Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Herpes Zoster Ophthalmicus Drug Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Herpes Zoster Ophthalmicus Drug Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Herpes Zoster Ophthalmicus Drug Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Herpes Zoster Ophthalmicus Drug Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Herpes Zoster Ophthalmicus Drug Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Herpes Zoster Ophthalmicus Drug Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Herpes Zoster Ophthalmicus Drug Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Herpes Zoster Ophthalmicus Drug Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Herpes Zoster Ophthalmicus Drug Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Herpes Zoster Ophthalmicus Drug Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Herpes Zoster Ophthalmicus Drug Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Herpes Zoster Ophthalmicus Drug Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Herpes Zoster Ophthalmicus Drug Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Herpes Zoster Ophthalmicus Drug Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Herpes Zoster Ophthalmicus Drug Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Herpes Zoster Ophthalmicus Drug Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Herpes Zoster Ophthalmicus Drug Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Herpes Zoster Ophthalmicus Drug Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Herpes Zoster Ophthalmicus Drug Market Size by Country (2022-2027) & (US$ Million)
Table 62. Abbott Company Details
Table 63. Abbott Business Overview
Table 64. Abbott Herpes Zoster Ophthalmicus Drug Product
Table 65. Abbott Revenue in Herpes Zoster Ophthalmicus Drug Business (2016-2021) & (US$ Million)
Table 66. Abbott Recent Development
Table 67. Novartis Company Details
Table 68. Novartis Business Overview
Table 69. Novartis Herpes Zoster Ophthalmicus Drug Product
Table 70. Novartis Revenue in Herpes Zoster Ophthalmicus Drug Business (2016-2021) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. GlaxoSmithKline Company Details
Table 73. GlaxoSmithKline Business Overview
Table 74. GlaxoSmithKline Herpes Zoster Ophthalmicus Drug Product
Table 75. GlaxoSmithKline Revenue in Herpes Zoster Ophthalmicus Drug Business (2016-2021) & (US$ Million)
Table 76. GlaxoSmithKline Recent Development
Table 77. Fresenius Company Details
Table 78. Fresenius Business Overview
Table 79. Fresenius Herpes Zoster Ophthalmicus Drug Product
Table 80. Fresenius Revenue in Herpes Zoster Ophthalmicus Drug Business (2016-2021) & (US$ Million)
Table 81. Fresenius Recent Development
Table 82. SteriMax Company Details
Table 83. SteriMax Business Overview
Table 84. SteriMax Herpes Zoster Ophthalmicus Drug Product
Table 85. SteriMax Revenue in Herpes Zoster Ophthalmicus Drug Business (2016-2021) & (US$ Million)
Table 86. SteriMax Recent Development
Table 87. Cadila Pharmaceuticals Company Details
Table 88. Cadila Pharmaceuticals Business Overview
Table 89. Cadila Pharmaceuticals Herpes Zoster Ophthalmicus Drug Product
Table 90. Cadila Pharmaceuticals Revenue in Herpes Zoster Ophthalmicus Drug Business (2016-2021) & (US$ Million)
Table 91. Cadila Pharmaceuticals Recent Development
Table 92. Shermco Company Details
Table 93. Shermco Business Overview
Table 94. Shermco Herpes Zoster Ophthalmicus Drug Product
Table 95. Shermco Revenue in Herpes Zoster Ophthalmicus Drug Business (2016-2021) & (US$ Million)
Table 96. Shermco Recent Development
Table 97. TEVA Company Details
Table 98. TEVA Business Overview
Table 99. TEVA Revenue in Herpes Zoster Ophthalmicus Drug Business (2016-2021) & (US$ Million)
Table 100. TEVA Recent Development
Table 101. Cipla Company Details
Table 102. Cipla Business Overview
Table 103. Cipla Herpes Zoster Ophthalmicus Drug Product
Table 104. Cipla Revenue in Herpes Zoster Ophthalmicus Drug Business (2016-2021) & (US$ Million)
Table 105. Cipla Recent Development
Table 106. Mylan Company Details
Table 107. Mylan Business Overview
Table 108. Mylan Herpes Zoster Ophthalmicus Drug Product
Table 109. Mylan Revenue in Herpes Zoster Ophthalmicus Drug Business (2016-2021) & (US$ Million)
Table 110. Mylan Recent Development
Table 111. Foamix Company Details
Table 112. Foamix Business Overview
Table 113. Foamix Herpes Zoster Ophthalmicus Drug Product
Table 114. Foamix Revenue in Herpes Zoster Ophthalmicus Drug Business (2016-2021) & (US$ Million)
Table 115. Foamix Recent Development
Table 116. Merck Company Details
Table 117. Merck Business Overview
Table 118. Merck Herpes Zoster Ophthalmicus Drug Product
Table 119. Merck Revenue in Herpes Zoster Ophthalmicus Drug Business (2016-2021) & (US$ Million)
Table 120. Merck Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Herpes Zoster Ophthalmicus Drug Market Share by Type: 2020 VS 2027
Figure 2. Oral Drug Features
Figure 3. Topical Drug Features
Figure 4. Injectable Drug Features
Figure 5. Global Herpes Zoster Ophthalmicus Drug Market Share by Application: 2020 VS 2027
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Herpes Zoster Ophthalmicus Drug Report Years Considered
Figure 10. Global Herpes Zoster Ophthalmicus Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Herpes Zoster Ophthalmicus Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Herpes Zoster Ophthalmicus Drug Market Share by Regions: 2020 VS 2027
Figure 13. Global Herpes Zoster Ophthalmicus Drug Market Share by Regions (2022-2027)
Figure 14. Global Herpes Zoster Ophthalmicus Drug Market Share by Players in 2020
Figure 15. Global Top Herpes Zoster Ophthalmicus Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herpes Zoster Ophthalmicus Drug as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Herpes Zoster Ophthalmicus Drug Revenue in 2020
Figure 17. Global Herpes Zoster Ophthalmicus Drug Revenue Market Share by Type (2016-2021)
Figure 18. Global Herpes Zoster Ophthalmicus Drug Revenue Market Share by Type (2022-2027)
Figure 19. North America Herpes Zoster Ophthalmicus Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Herpes Zoster Ophthalmicus Drug Market Share by Type (2016-2027)
Figure 21. North America Herpes Zoster Ophthalmicus Drug Market Share by Application (2016-2027)
Figure 22. North America Herpes Zoster Ophthalmicus Drug Market Share by Country (2016-2027)
Figure 23. United States Herpes Zoster Ophthalmicus Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Herpes Zoster Ophthalmicus Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Herpes Zoster Ophthalmicus Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Herpes Zoster Ophthalmicus Drug Market Share by Type (2016-2027)
Figure 27. Europe Herpes Zoster Ophthalmicus Drug Market Share by Application (2016-2027)
Figure 28. Europe Herpes Zoster Ophthalmicus Drug Market Share by Country (2016-2027)
Figure 29. Germany Herpes Zoster Ophthalmicus Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Herpes Zoster Ophthalmicus Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Herpes Zoster Ophthalmicus Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Herpes Zoster Ophthalmicus Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Herpes Zoster Ophthalmicus Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Herpes Zoster Ophthalmicus Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Herpes Zoster Ophthalmicus Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Herpes Zoster Ophthalmicus Drug Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Herpes Zoster Ophthalmicus Drug Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Herpes Zoster Ophthalmicus Drug Market Share by Region (2016-2027)
Figure 39. China Herpes Zoster Ophthalmicus Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Herpes Zoster Ophthalmicus Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Herpes Zoster Ophthalmicus Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Herpes Zoster Ophthalmicus Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Herpes Zoster Ophthalmicus Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Herpes Zoster Ophthalmicus Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Herpes Zoster Ophthalmicus Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Herpes Zoster Ophthalmicus Drug Market Share by Type (2016-2027)
Figure 47. Latin America Herpes Zoster Ophthalmicus Drug Market Share by Application (2016-2027)
Figure 48. Latin America Herpes Zoster Ophthalmicus Drug Market Share by Country (2016-2027)
Figure 49. Mexico Herpes Zoster Ophthalmicus Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Herpes Zoster Ophthalmicus Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Herpes Zoster Ophthalmicus Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Herpes Zoster Ophthalmicus Drug Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Herpes Zoster Ophthalmicus Drug Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Herpes Zoster Ophthalmicus Drug Market Share by Country (2016-2027)
Figure 55. Turkey Herpes Zoster Ophthalmicus Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Herpes Zoster Ophthalmicus Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Herpes Zoster Ophthalmicus Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Abbott Revenue Growth Rate in Herpes Zoster Ophthalmicus Drug Business (2016-2021)
Figure 59. Novartis Revenue Growth Rate in Herpes Zoster Ophthalmicus Drug Business (2016-2021)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Herpes Zoster Ophthalmicus Drug Business (2016-2021)
Figure 61. Fresenius Revenue Growth Rate in Herpes Zoster Ophthalmicus Drug Business (2016-2021)
Figure 62. SteriMax Revenue Growth Rate in Herpes Zoster Ophthalmicus Drug Business (2016-2021)
Figure 63. Cadila Pharmaceuticals Revenue Growth Rate in Herpes Zoster Ophthalmicus Drug Business (2016-2021)
Figure 64. Shermco Revenue Growth Rate in Herpes Zoster Ophthalmicus Drug Business (2016-2021)
Figure 65. TEVA Revenue Growth Rate in Herpes Zoster Ophthalmicus Drug Business (2016-2021)
Figure 66. Cipla Revenue Growth Rate in Herpes Zoster Ophthalmicus Drug Business (2016-2021)
Figure 67. Mylan Revenue Growth Rate in Herpes Zoster Ophthalmicus Drug Business (2016-2021)
Figure 68. Foamix Revenue Growth Rate in Herpes Zoster Ophthalmicus Drug Business (2016-2021)
Figure 69. Merck Revenue Growth Rate in Herpes Zoster Ophthalmicus Drug Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[眼部帯状ヘルペス治療薬の世界市場規模・現状・予測2021年-2027年] (Global Herpes Zoster Ophthalmicus Drug Market Size, Status and Forecast 2021-2027 / QY21APR2814)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆